OCS

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Oculis Holding AG Ordinary shares

NASDAQ | OCS

18.93

USD

+$0.00

(

+0.00%

)

At Close (As of Dec 3, 2025)

$1.09B

Market Cap

-

P/E Ratio

-2.66

EPS

$23.08

52 Week High

$14.00

52 Week Low

HEALTHCARE

Sector

OCS Chart

Recent Chart
Price Action

OCS Technicals

Tags:

OCS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$51M
Total Revenue $686K
Cost Of Revenue $52M
Costof Goods And Services Sold $52M
Operating Income -$73M
Selling General And Administrative $22M
Research And Development $52M
Operating Expenses $22M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.2M
Interest Expense $639K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $406K
Income Before Tax -$86M
Income Tax Expense -$160K
Interest And Debt Expense -
Net Income From Continuing Operations -$86M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$73M
Net Income -$86M

Revenue & Profitability

Earnings Performance

OCS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (CHF)
Total Assets $120M
Total Current Assets $105M
Cash And Cash Equivalents At Carrying Value $28M
Cash And Short Term Investments $28M
Inventory -
Current Net Receivables $777K
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $13M
Intangible Assets Excluding Goodwill $13M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $71M
Other Current Assets $5.5M
Other Non Current Assets -
Total Liabilities $47M
Total Current Liabilities $44M
Current Accounts Payable $5.9M
Deferred Revenue -
Current Debt -
Short Term Debt $315K
Total Non Current Liabilities $2.7M
Capital Lease Obligations $1.2M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.2M
Other Current Liabilities $38M
Other Non Current Liabilities -
Total Shareholder Equity $73M
Treasury Stock -
Retained Earnings -$286M
Common Stock $446K
Common Stock Shares Outstanding $40M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (CHF)
Operating Cashflow -$47M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $406K
Capital Expenditures $230K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$18M
Cashflow From Financing $54M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$86M

yearly Income Statement (As of Dec 31, 2024)

Field Value (CHF)
Gross Profit -$51M
Total Revenue $686K
Cost Of Revenue $52M
Costof Goods And Services Sold $52M
Operating Income -$73M
Selling General And Administrative $22M
Research And Development $52M
Operating Expenses $22M
Investment Income Net -
Net Interest Income $1.5M
Interest Income $2.2M
Interest Expense $639K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $406K
Income Before Tax -$86M
Income Tax Expense -$160K
Interest And Debt Expense -
Net Income From Continuing Operations -$86M
Comprehensive Income Net Of Tax -
Ebit -$73M
Ebitda -$73M
Net Income -$86M

OCS News

OCS Profile

Oculis Holding AG Ordinary shares Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Oculis Holding AG is a pioneering biopharmaceutical company located in Zug, Switzerland, dedicated to transforming the treatment landscape for ophthalmic diseases through its innovative topical therapies. Utilizing cutting-edge formulation technologies, Oculis targets significant unmet medical needs in vision care, aiming to improve patient outcomes with convenient and effective therapies. With a strong pipeline of products addressing both acute and chronic eye conditions, the company is well-positioned to make a substantial impact in the ophthalmology sector, thus attracting the attention of institutional investors seeking opportunities in novel therapeutic solutions.

LPTX
+368.57%
$2.05
PAVS
-37.38%
$0.03
VRAX
+37.97%
$0.54
IXHL
+14.39%
$0.45
IRBT
+74.87%
$3.41
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.23%
$181.04
ONDS
-1.47%
$7.95
IPG
-1.95%
$24.57
KITT
+61.91%
$1.17
NIO
-5.56%
$4.75
AXDX
-61.36%
$0.03
PLUG
+3.08%
$2.17
ASST
-1.98%
$1.01
RR
+15.58%
$4.11
BITF
-1.77%
$3.04
TSLA
+4.23%
$447.43
BYND
-7.01%
$1.19
ADAP
-15.14%
$0.05
CAPR
+353.69%
$28.85
INTC
+0.21%
$43.56
IREN
+5.58%
$43.41
VALE
+3.45%
$13.33
QCLS
+38.16%
$4.67
AAL
+2.03%
$14.53
SOND
-23.45%
$0.12
YGMZ
-21.06%
$0.08
INHD
-8.15%
$0.13
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
BMNR
+3.68%
$33.08
ADD
-25.47%
$0.05
MRVL
+6.22%
$98.67
SOFI
-1.25%
$29.14
SRM
+53.27%
$10.30
BMNU
+4.90%
$7.70
PFE
+2.33%
$25.73
DNN
+2.70%
$2.66
NFLX
-5.40%
$103.43
BBD
-2.45%
$3.58
T
-1.04%
$25.52
F
+0.93%
$13.08
WLGS
-5.57%
$0.04
ACHR
+5.29%
$8.05
MTSR
-0.35%
$70.50
PLTD
-2.01%
$6.81
AEO
+13.53%
$23.64
KVUE
-0.54%
$16.76
AFMD
-34.94%
$0.18
MARA
+2.97%
$12.26
AAPL
-0.28%
$285.36
CIFR
+2.29%
$18.04
QBTS
+5.45%
$23.72
AVGO
-1.16%
$381.57
AMZN
-1.07%
$231.89
IMRN
-10.05%
$1.56
WULF
-1.14%
$14.05
BTBT
+0.24%
$2.24
MSFT
-1.69%
$481.70
ASBP
-8.60%
$0.09
GOOGL
+1.58%
$320.82
PMAX
+27.97%
$2.90
CLSK
+3.17%
$14.14
CHR
-5.80%
$0.04
PLTR
+2.06%
$174.21
HTOO
+6.74%
$3.73
AMD
+0.69%
$216.72
CMND
-12.88%
$0.11
CGC
+4.95%
$1.16
GRYP
-10.38%
$1.38
PYPL
-3.07%
$60.96
BTG
+0.56%
$4.45
MODV
-25.22%
$0.43
BAC
+1.67%
$54.08
PCG
-1.01%
$15.16
MSTR
+2.50%
$185.87
HOOD
+5.39%
$132.74
JOBY
+2.67%
$13.83
RIG
+3.03%
$4.44
AKTX
-14.10%
$0.34
RIVN
+0.20%
$17.26
M
+1.91%
$23.14
DVLT
-3.72%
$1.81
ABEV
+1.34%
$2.61
BE
+6.13%
$105.00
BMY
+5.66%
$50.98
PSTG
-27.13%
$69.02
HBAN
+2.64%
$16.99
VIVK
-13.71%
$0.09
CRCL
+7.27%
$83.07
ITUB
+0.24%
$7.90
CAN
-1.26%
$0.95
RGTI
+2.15%
$24.39
NOK
+0.40%
$6.21
ALIT
-1.12%
$2.20
KDLY
-2.95%
$0.48
GRAB
-0.76%
$5.22
SAND
-6.04%
$12.12
TSLG
+7.92%
$9.93
LPTX
+368.57%
$2.05
PAVS
-37.38%
$0.03
VRAX
+37.97%
$0.54
IXHL
+14.39%
$0.45
IRBT
+74.87%
$3.41
VHAI
0.00%
$0.00
TWOH
0.00%
$0.00
NVDA
-0.23%
$181.04
ONDS
-1.47%
$7.95
IPG
-1.95%
$24.57
KITT
+61.91%
$1.17
NIO
-5.56%
$4.75
AXDX
-61.36%
$0.03
PLUG
+3.08%
$2.17
ASST
-1.98%
$1.01
RR
+15.58%
$4.11
BITF
-1.77%
$3.04
TSLA
+4.23%
$447.43
BYND
-7.01%
$1.19
ADAP
-15.14%
$0.05
CAPR
+353.69%
$28.85
INTC
+0.21%
$43.56
IREN
+5.58%
$43.41
VALE
+3.45%
$13.33
QCLS
+38.16%
$4.67
AAL
+2.03%
$14.53
SOND
-23.45%
$0.12
YGMZ
-21.06%
$0.08
INHD
-8.15%
$0.13
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
BMNR
+3.68%
$33.08
ADD
-25.47%
$0.05
MRVL
+6.22%
$98.67
SOFI
-1.25%
$29.14
SRM
+53.27%
$10.30
BMNU
+4.90%
$7.70
PFE
+2.33%
$25.73
DNN
+2.70%
$2.66
NFLX
-5.40%
$103.43
BBD
-2.45%
$3.58
T
-1.04%
$25.52
F
+0.93%
$13.08
WLGS
-5.57%
$0.04
ACHR
+5.29%
$8.05
MTSR
-0.35%
$70.50
PLTD
-2.01%
$6.81
AEO
+13.53%
$23.64
KVUE
-0.54%
$16.76
AFMD
-34.94%
$0.18
MARA
+2.97%
$12.26
AAPL
-0.28%
$285.36
CIFR
+2.29%
$18.04
QBTS
+5.45%
$23.72
AVGO
-1.16%
$381.57
AMZN
-1.07%
$231.89
IMRN
-10.05%
$1.56
WULF
-1.14%
$14.05
BTBT
+0.24%
$2.24
MSFT
-1.69%
$481.70
ASBP
-8.60%
$0.09
GOOGL
+1.58%
$320.82
PMAX
+27.97%
$2.90
CLSK
+3.17%
$14.14
CHR
-5.80%
$0.04
PLTR
+2.06%
$174.21
HTOO
+6.74%
$3.73
AMD
+0.69%
$216.72
CMND
-12.88%
$0.11
CGC
+4.95%
$1.16
GRYP
-10.38%
$1.38
PYPL
-3.07%
$60.96
BTG
+0.56%
$4.45
MODV
-25.22%
$0.43
BAC
+1.67%
$54.08
PCG
-1.01%
$15.16
MSTR
+2.50%
$185.87
HOOD
+5.39%
$132.74
JOBY
+2.67%
$13.83
RIG
+3.03%
$4.44
AKTX
-14.10%
$0.34
RIVN
+0.20%
$17.26
M
+1.91%
$23.14
DVLT
-3.72%
$1.81
ABEV
+1.34%
$2.61
BE
+6.13%
$105.00
BMY
+5.66%
$50.98
PSTG
-27.13%
$69.02
HBAN
+2.64%
$16.99
VIVK
-13.71%
$0.09
CRCL
+7.27%
$83.07
ITUB
+0.24%
$7.90
CAN
-1.26%
$0.95
RGTI
+2.15%
$24.39
NOK
+0.40%
$6.21
ALIT
-1.12%
$2.20
KDLY
-2.95%
$0.48
GRAB
-0.76%
$5.22
SAND
-6.04%
$12.12
TSLG
+7.92%
$9.93
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.